Dr. Michael Yung-Shun Wang, MD

Dr. Wang practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Wang's NPI, 1053347906, was assigned on June 23, 2006. Dr. Wang graduated from Stanford University School Of Medicine in 1991. Dr. Wang holds Florida license ME0082367.

Dr. Wang's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Wang's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Wang is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Wang to 3 more hospitals, 5 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 12 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Wang is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Wang's licenses on file in 2 states: Florida and California.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. Wang treats.

CMS data shows 2,045 Medicare services from Dr. Wang across 22 procedure codes in 2024, for 661 Medicare patients. Medicare paid $825,698 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 661 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 306 patients. 75% of them have arthritis, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 72, with 48% women.

In 2024, Dr. Wang wrote 2,393 Medicare Part D claims for 651 patients. 99% of them were for generic drugs. CMS names the drug for 2,227 of them, across 18 drugs with 11 or more claims each, at $29,512 in total drug cost. In 2023, CMS named 1,856 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 865 procedures of spinal fusion by Dr. Wang, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 427 papers to Dr. Wang, published from 2002 to 2025. 2024 was the busiest year, with 25. The most frequent topics are Spinal Fusion, Lumbar Vertebrae and Cervical Vertebrae. Dr. Wang has published most often in J Neurosurg Spine. Dr. Wang's most frequent co-authors are Michael Y. Wang, MD, Praveen V. Mummaneni, MD and Mohamad Bydon, MD.

Dmand AI links Dr. Wang to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Spondylolisthesis and Spondylolysis.

CMS Open Payments shows 1,540 general payments to Dr. Wang from 50 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 46% of the total. DePuy Synthes Sales Inc. paid the most, $1,574,322. It also lists 6 research payments totaling $87,560 from 2020 to 2023.

Dmand AI lists 1 award for Dr. Wang, most recently Grand Rounds Lecturer in 2018.

Dr. Wang graduated from Stanford University School Of Medicine in 1991. Dr. Wang is a member of AANS.

Dr. Wang is in network with 11 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.